| Size & multiples | |||
| Market Cap | $31.08B | Enterprise Value | $29.83B |
| P/E (TTM) | 22.53× | PEG (trailing) | 1.05× |
| P/S | 5.54× | P/FCF | 17.72× |
| EV/EBITDA | 14.12× | EV/EBIT | 15.76× |
| EV/Sales | 5.31× | EV/FCF | 17.00× |
| FCF Yield | 5.64% | Buyback Yield | 1.93% |
| Owner Earnings (TTM) | $1.60B | Owner Earnings Yield | 5.16% |
| Shareholder Yield | 3.02% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.72 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 7.61% |
| After-tax Cost of Debt | 4.63% | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | 5.55% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 7.57% | ROIC | 26.21% |
| EVA Spread (ROIC−WACC) | 18.63% | EVA | $1.01B |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $9.51 · revenue TTM $5.61B · FCF TTM $1.75B
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E; rich on EV/EBITDA
P/E 46th · EV/EBITDA 54th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 22.5x | 24.4x | 12.9x–38.8x | 46 ↓cheap |
| EV/EBITDA | 16.2x | 15.2x | 9.9x–24.7x | 54 ↑rich |
| FCF Yield | 5.3% | -7.9% | -35.6%–1.4% | 88 ↑strong |
| Dividend Yield | 1.0% | 1.1% | 0.2%–2.4% | 46 ↓weak |
| Net Margin | 27.2% | -21.2% | -325.3%–7.2% | 92 ↑strong |
| Operating Margin | 32.7% | -34.5% | -552.0%–8.0% | 97 ↑strong |
| ROE | 25.9% | -36.8% | -92.5%–4.5% | 93 ↑strong |
